All In Biotech

Drug Trial Radar · NCT00400387

Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss

Phase III Study Analyzing the Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss

Last checked: Nov 20, 2026Latest source record: Sep 17, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 449 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

449

Actual

Start

Nov 2006

Primary completion

Dec 2012

Study completion Apr 2013

Sponsor

Lead sponsor
University of JenaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 16, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

With this clinical trial the investigators will analyze whether the rate of pregnancy losses before the 24th week of gestation can be reduced by dalteparin treatment in habitual aborters.

Conditions

  • Abortion, Habitual

Interventions

  • Fragmin P Forte (dalteparin sodium)Drug

    subcutaneous injection, once daily supported by multivitamine supplement and close monitoring

  • Multivitamin supplementDietary supplement

    general pregnancy support by multivitamin supplementation and close monitoring

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ongoing intact pregnancy at 24 weeks of gestationTime frame: at 24 weeks of gestation

Locations

12 sites in 2 countries. Site status is shown where the registry gives one.

  • Kinderwunschinstitut Schenk

    Dobl, Austria

  • Universitätsfrauenklinik am Universitätsklinikum "Carl Gustav Carus" der Technischen Universität Dresden

    Dresden, Germany

  • Krankenhaus St. Elisabeth und St. Barbara, Klinik für Frauenheilkunde und Geburtshilfe

    Halle, Germany

  • Medizinische Hochschule Hannover, Abt. für Gynäkologie und Geburtshilfe

    Hanover, Germany

  • Frauenklinik Landshut Achdorf

    Landshut, Germany

  • Universitätsklinikum Schleswig-Holstein

    Lübeck, Germany

  • Klinikum der Universität München Großhadern, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe

    München, Germany

  • Frauenklinik der Technischen Universität München, Klinikum rechts der Isa

    München, Germany

  • Praxis für medizinische Genetik

    Regensburg, Germany

  • Klinikum Stuttgart, Frauenklinik

    Stuttgart, Germany

  • Universitätsfrauenklinik Tübingen

    Tübingen, Germany

  • Martin-Luther-Universität Halle Wittenberg

    Halle, Saxony-Anhalt, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.